Solvay SA 2009 AR2
The report highlights Solvay's performance and strategic transition during the 2009 fiscal year, marked by the global economic crisis and the decision to sell its Pharmaceuticals Sector to Abbott. The company demonstrated resilience, posting a recurring operating income (REBIT) of EUR 905 million despite an 11% decline in sales. Solvay accelerated its sustainable development strategy, committing to reduce energy consumption and greenhouse gas emissions by 20% by 2020 compared to 2006 levels. Key achievements include the deployment of sustainable development indicators, progress in occupational safety with a record low accident rate, and the integration of innovative materials in the Solar Impulse project.
Company: Solvay SA
Sector: Manufacturing
Country: Belgium
Year: 2009
Type: AR2
Pages: 186
Back to company
Solvay SA
Annual Report
The report highlights Solvay's performance and strategic transition during the 2009 fiscal year, marked by the global economic crisis and the decision to sell its Pharmaceuticals Sector to Abbott. The company demonstrated resilience, posting a recurring operating income (REBIT) of EUR 905 million despite an 11% decline in sales. Solvay accelerated its sustainable development strategy, committing to reduce energy consumption and greenhouse gas emissions by 20% by 2020 compared to 2006 levels. Key achievements include the deployment of sustainable development indicators, progress in occupational safety with a record low accident rate, and the integration of innovative materials in the Solar Impulse project.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2009
Reporting Period
Jan 1, 2009 - Dec 31, 2009
Fiscal Year
2009
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Energy Consumption
Employees